Inscription Capital »

4d Molecular Therapeutics In shares owned by Inscription Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $94k 11k 8.69

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Nike CL B (NKE)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Chevron Corporation (CVX)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)

View all positions for Inscription Capital

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In